Healthcare Realty Trust (HR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 20, 2025, to elect 11 directors, ratify the auditor, and hold a say-on-pay vote.
Board recommends voting FOR all director nominees, auditor ratification, and executive compensation.
Record date for voting is March 27, 2025, with 350,996,169 shares outstanding.
Proxy materials are distributed electronically, with options for mail or email upon request.
Voting matters and shareholder proposals
Election of 11 directors for one-year terms.
Ratification of BDO USA, P.C. as independent auditor for 2025.
Non-binding advisory vote on executive compensation (say-on-pay).
Board recommends FOR all proposals.
Shareholders may submit proposals or director nominations for the 2026 meeting by December 9, 2025.
Board of directors and corporate governance
Board reduced from 13 to 11 members in 2024, with five retirements and three new directors added.
Board chair and CEO roles are separated; independent chair presides over executive sessions.
All committees are composed of independent directors.
Proxy access allows qualifying shareholders to nominate directors.
Board diversity includes three women and two racial/ethnic minorities among nominees.
Latest events from Healthcare Realty Trust
- Strong leasing, $1.2B asset sales, and improved leverage drive positive 2025 and 2026 outlook.HR
Q4 202513 Feb 2026 - Q2 net loss on impairments, but strong leasing, asset sales, and FFO guidance affirmed.HR
Q2 20242 Feb 2026 - Normalized FFO per share rose 1.2% as leasing, asset sales, and share buybacks drove activity.HR
Q3 202417 Jan 2026 - Record leasing, robust FFO growth, and deleveraging highlight 2024 performance.HR
Q4 202429 Dec 2025 - Normalized FFO per share was $0.39 in Q1 2025, with improved net loss and strong leasing.HR
Q1 202527 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.HR
Proxy Filing1 Dec 2025 - Q2 2025 saw strong FFO, higher guidance, a dividend cut, and major asset sales.HR
Q2 202516 Nov 2025 - Q3 2025 saw 5% FFO growth, strong leasing, asset sales, and improved guidance despite a net loss.HR
Q3 20252 Nov 2025